-
Clinical trial information system reaches major milestone
Clinical trial information system reaches major milestone
-
Clinical trial information system reaches major milestone
Clinical trial information system reaches major milestone
EMA’s Management Board confirms CTIS, one of the main deliverables of the Clinical Trial Regulation, is on track to go live by 31 January 2022.
-
Outcome of the PRAC review of COVID-19 Vaccine Janssen
Outcome of the PRAC review of COVID-19 Vaccine Janssen
-
Outcome of the PRAC review of COVID-19 Vaccine Janssen
Outcome of the PRAC review of COVID-19 Vaccine Janssen
EMA’s safety committee (PRAC) finds possible link to very rare cases of unusual blood clots with low blood platelets but overall benefit-risk remains positive
-
EMA continues to monitor COVID-19 vaccine AstraZeneca
EMA continues to monitor COVID-19 vaccine AstraZeneca
-
EMA continues to monitor COVID-19 vaccine AstraZeneca
EMA continues to monitor COVID-19 vaccine AstraZeneca
EMA to provide further context on risk of very rare blood clots with low blood platelets that occurred after vaccination with Vaxzevria
-
Development, evaluation and monitoring of COVID-19 vaccines
Development, evaluation and monitoring of COVID-19 vaccines
-
Development, evaluation and monitoring of COVID-19 vaccines
Development, evaluation and monitoring of COVID-19 vaccines
Read about how EMA is ensuring vaccines for COVID-19 meet the highest standards of quality, safety & efficacy while their development and approval is sped up due to the public health emergency.
